Efficacy of proton pump inhibitor in combination with rikkunshito in patients complaining of globus pharyngeus

J Med Invest. 2016;63(3-4):227-9. doi: 10.2152/jmi.63.227.

Abstract

Objective: Globus pharyngeus (GP) is a common symptom of laryngopharyngeal reflux disease (LPRD), and proton pump inhibitor (PPI) and rikkunshito, a traditional Japanese medicine having prokinetic effect improve LPRD symptoms. In the present study, we examined the efficacy of high-dose PPI in combination with rikkunshito in patients complaining of GP.

Methods: 106 patients complaining of GP without any organic endoscopic findings were enrolled.

Results: Patients were first administrated with high-dose PPI alone for 4 to 8 weeks and the symptom was improved in 65 patients. Among 41 patients with PPI-refractory GP, 22 patients were administrated with high-dose PPI in combination with rikkunshito, and the symptom was improved in 14 of 22 patients 4 weeks later. The average value of a modified reflux symptom index of the responders was similar to that of non-responders. Only a few patients had positive values in reflux finding scores in both groups.

Conclusion: The present findings suggest the existence of a high prevalence of LPRD in patients complaining of GP. The data also suggest that gastroesophageal dysmotility is involved in GP, in addition to excessive acid reflux. The pre-therapeutic laryngopharyngeal symptoms and endoscopic findings could not predict the efficacy of the treatment for GP. J. Med. Invest. 63: 227-229, August, 2016.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Drug Therapy, Combination
  • Drugs, Chinese Herbal / administration & dosage*
  • Female
  • Humans
  • Laryngopharyngeal Reflux / drug therapy*
  • Male
  • Middle Aged
  • Proton Pump Inhibitors / administration & dosage*

Substances

  • Drugs, Chinese Herbal
  • Proton Pump Inhibitors
  • liu-jun-zi-tang